Quick Answer
ImageneBio, Inc. reported Net Income of -$45.35 million for fiscal year 2025.
ImageneBio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$45.35M | -24.0% |
| 2024 | -$36.57M | +46.4% |
| 2023 | -$68.17M | +0.9% |
| 2022 | -$68.77M | -101.6% |
| 2021 | -$34.12M | +22.9% |
| 2020 | -$44.26M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$24.78M | -678.5% | -226.7% |
| June 30, 2025 | -$7.58M | -21.2% | -24.8% |
| March 31, 2025 | -$6.08M | +72.8% | -90.9% |
| September 30, 2024 | -$3.18M | +81.6% | +49.1% |
| June 30, 2024 | -$6.26M | +63.4% | +72.0% |
| March 31, 2024 | -$22.31M | -56.9% | -28.7% |
| September 30, 2023 | -$17.34M | -0.0% | -1.3% |
| June 30, 2023 | -$17.11M | +16.5% | -20.4% |
- ImageneBio, Inc. showed a decrease of -24.0% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, ImageneBio, Inc.’s net income has declined by 2.5% (from -$44.26 million to -$45.35 million).
- The most recent figure is from ImageneBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: